37 research outputs found
The Effect of the Dicto-gloss as a Cooperative Learning Technique on EFL Learners' Self-efficacy in Writing
This study investigates the effect of Dicto-gloss as a cooperative learning technique on the perceived self-efficacy of Iranian EFL learners in writing. There were 46 Persian speaking EFL learners participated in this study. Out of 46, 23 participants were taken as the experimental group and the other 23 as the control group. They were heterogeneous due to the cooperative nature of the study. As the first phase of data collection, a self-efficacy in writing questionnaire developed by Yavuz-Erkan (2004) was administered to both groups as a pretest in order to evaluate the degree of their self-efficacy in writing. The experimental group was exposed to the Dicto-gloss technique of cooperative learning, while the control group was exposed to the traditional method of writing instruction in TEFL writing classes. After 13 sessions of treatment, the self-efficacy in writing questionnaire was reapplied to both groups as the post test. The participants' scores in the two groups were calculated and compared. The results revealed a difference between the two groups, indicating the effects of THE dicto-gloss technique of cooperative learning on self-efficacy in the writing of EFL learners.
Current Research of the Renin-Angiotensin System Effect on Stem Cell Therapy
The renin-angiotensin system (RAS) is a chief regulator of the cardiovascular system and body fluid homeostasis. Stem/progenitor cell therapy has pointed towards a novel tool for medical and therapeutic intervention. In addition to the physiological and pathological role of the RAS and its pharmacological inhibitors, the proliferation, differentiation in stem cells is mediated through various cell-signalling pathways. This book chapter reviews the new role of RAS components, distinct from other common roles by considering its regulating impact on the several signalling pathways involved in different body tissues, as well as in stem cell therapy
Evaluating of novel thiazolidinone compounds with hypnotic effects
Introduction: Insomnia is a common problem among the people all over the world. This problem affects both sleep’s quantity and quality. Among sedative-hypnotic drugs, barbiturates are more toxic than benzodiazepines. Besides, current benzodiazepines have many side effects like dependence, muscle relaxation, and withdrawal syndrome. Attention to synthesize novel benzodiazepine like derivatives, which have fewer side effects, has been improved. Thiazolidinone derivatives are novel benzodiazepine-like compounds that have all pharmacophores like lipophilic group and aromatic ring for binding to the benzodiazepine receptor (GABA).
Methods and Results: In this research hypnotic effect of two novel thiazolidinone derivatives were evaluated, using pentobarbital-induced loss of righting reflex test. Open field test, was used to evaluate the locomotor activity of the mice in all groups. Male mice in the range of 18-25 g of weight were used in all tests. Moreover, diazepam and flumazenil were used as an agonist and antagonist of GABA-A receptor respectively to indicate that the novel compounds show their effects through interacting with benzodiazepine receptors. Compound SM4 at the dose of 20, 30, and 40 mg/kg (i.p.) and compound SM6 at the dose of 30 and 40 mg/kg (i.p.) increased the sleeping time dose-dependently and showed significant hypnotic effects compared to the control group in the righting reflex test. Also, the sleeping time was decreased by the injection of flumazenil as an antagonist of GABA-A receptor after the injection of each compound. In the open field test, both compounds at the dose of 20, 30, and 40 mg/kg (i.p.) decreased the total distance moved which indicates sedative effect of the novel compounds.
Conclusions:The results indicate that both compounds (SM4 and SM6) have sedative-hypnotic effects, which may be due to an interaction between novel benzodiazepine-like compounds and GABA-A receptor. We recommend further studies to determine the exact mechanism of action and toxicity of the novel compounds
Vitamin D Receptor and Vitamin D Binding Protein Gene Polymorphisms Are Associated with Renal Allograft Outcome
Vitamin D deficiency has adverse effects on renal allograft outcomes, and polymorphisms
of genes encoding vitamin D-binding protein (VDBP) and vitamin D receptor (VDR) are defined to
play a role in these conditions. The goal of the current investigation was to evaluate the connection
between those polymorphisms with acute rejection, viral infection history, and recipients’ vitamin
D status. In this study, 115 kidney transplant recipients and 100 healthy individuals were included.
VDR polymorphisms including FokI (rs2228570), Apal (rs7975232), BsmI (rs1544410), as well as VDBP
(rs7040) polymorphisms were studied using high resolution melting (PCR-HRM) analysis among the
studied groups. The frequency of G allele in Apal rs7975232 polymorphism in the kidney transplant
recipients was 0.63 times lower than healthy individuals (p = 0.026). Further, the G allele frequency
in VDBP rs7040 polymorphism was significantly lower in patients with allograft rejection (p = 0.002).
Considering the incidence of viral infection, significant differences were identified between the
frequencies of VDR FokI (OR = 2.035; 95% CI 1.06–2.89, p = 0.030) and VDBP rs7040 (OR = 0.40; 95%
CI 0.24–0.67, p < 0.001) T alleles in the studied groups. Moreover, the VDBP rs7040 GG genotype
distribution was low in the recipients with a history of viral infection (p = 0.004). VDR (FokI) and
VDBP (rs7040) alleles and their genotype distribution are significantly associated with allograft
outcomes including allograft rejection and viral infection in the studied population
Cytoprotective Properties of Carnosine against Isoniazid-Induced Toxicity in Primary Cultured Rat Hepatocytes
Background: Drug-induced liver injury is a critical clinical complication. Hence, finding new and safe protective agents with potential clinical application is of value. Isoniazid (INH) is an antituberculosis agent widely used against Mycobacterium tuberculosis infection in human. On the other hand, hepatotoxicity is a clinical complication associated with isoniazid therapy. Oxidative stress and its associated events are major mechanisms identified for INH-induced liver injury. Carnosine is an endogenously found peptide widely investigated for its hepatoprotective effects. On the other hand, robust antioxidant and cytoprotective effects have been attributed to this peptide. Methods: The current study designed to evaluate the potential cytoprotective properties of carnosine against INH-induced cytotoxicity in drug-exposed primary cultured rat hepatocytes. Primary cultured rat hepatocytes were incubated with INH (1.2 mM). Results: INH treatment caused significant increase in cell death and lactate dehydrogenase (LDH) release. On the other hand, it was found that markers of oxidative stress including reactive oxygen species were significantly increased in INH-treated cells. Cellular glutathione reservoirs were also depleted in INH-treated group. Carnosine treatment (50 and 100 µM) significantly diminished INH-induced oxidative stress and cytotoxicity. Conclusion: These data mention carnosine as a potential protective agent with therapeutic capability against INH hepatotoxicity
Recommended from our members
The Use of Infrapatellar Fat Pad-Derived Mesenchymal Stem Cells in Articular Cartilage Regeneration: A Review.
Cartilage is frequently damaged with a limited capacity for repair. Current treatment strategies are insufficient as they form fibrocartilage as opposed to hyaline cartilage, and do not prevent the progression of degenerative changes. There is increasing interest in the use of autologous mesenchymal stem cells (MSC) for tissue regeneration. MSCs that are used to treat articular cartilage defects must not only present a robust cartilaginous production capacity, but they also must not cause morbidity at the harvest site. In addition, they should be easy to isolate from the tissue and expand in culture without terminal differentiation. The source of MSCs is one of the most important factors that may affect treatment. The infrapatellar fat pad (IPFP) acts as an important reservoir for MSC and is located in the anterior compartment of the knee joint in the extra-synovial area. The IPFP is a rich source of MSCs, and in this review, we discuss studies that demonstrate that these cells have shown many advantages over other tissues in terms of ease of isolation, expansion, and chondrogenic differentiation. Future studies in articular cartilage repair strategies and suitable extraction as well as cell culture methods will extend the therapeutical application of IPFP-derived MSCs into additional orthopedic fields, such as osteoarthritis. This review provides the latest research concerning the use of IPFP-derived MSCs in the treatment of articular cartilage damage, providing critical information for the field to grow
Effect of gelatinous spongy scaffold containing nano-hydroxyapatite on the induction of odontogenic activity of dental pulp stem cells
A Comprehensive Review of Detection Methods for SARS-CoV-2
Recently, the outbreak of the coronavirus disease 2019 (COVID-19), caused by the SARSCoV-2 virus, in China and its subsequent spread across the world has caused numerous infections and
deaths and disrupted normal social activity. Presently, various techniques are used for the diagnosis of
SARS-CoV-2 infection, with various advantages and weaknesses to each. In this paper, we summarize
promising methods, such as reverse transcription-polymerase chain reaction (RT-PCR), serological
testing, point-of-care testing, smartphone surveillance of infectious diseases, nanotechnology-based
approaches, biosensors, amplicon-based metagenomic sequencing, smartphone, and wastewaterbased epidemiology (WBE) that can also be utilized for the detection of SARS-CoV-2. In addition,
we discuss principles, advantages, and disadvantages of these detection methods, and highlight
the potential methods for the development of additional techniques and products for early and fast
detection of SARS-CoV-2
Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017 : a systematic analysis for the Global Burden of Disease Study 2017
Background Previous attempts to characterise the burden of chronic respiratory diseases have focused only on specific disease conditions, such as chronic obstructive pulmonary disease (COPD) or asthma. In this study, we aimed to characterise the burden of chronic respiratory diseases globally, providing a comprehensive and up-to-date analysis on geographical and time trends from 1990 to 2017.
Methods Using data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017, we estimated the prevalence, morbidity, and mortality attributable to chronic respiratory diseases through an analysis of deaths, disability-adjusted life-years (DALYs), and years of life lost (YLL) by GBD super-region, from 1990 to 2017, stratified by age and sex. Specific diseases analysed included asthma, COPD, interstitial lung disease and pulmonary sarcoidosis, pneumoconiosis, and other chronic respiratory diseases. We also assessed the contribution of risk factors (smoking, second-hand smoke, ambient particulate matter and ozone pollution, household air pollution from solid fuels, and occupational risks) to chronic respiratory disease-attributable DALYs.
Findings In 2017, 544.9 million people (95% uncertainty interval [UI] 506.9- 584.8) worldwide had a chronic respiratory disease, representing an increase of 39.8% compared with 1990. Chronic respiratory disease prevalence showed wide variability across GBD super-regions, with the highest prevalence among both males and females in high-income regions, and the lowest prevalence in sub-Saharan Africa and south Asia. The age-sex- specific prevalence of each chronic respiratory disease in 2017 was also highly variable geographically. Chronic respiratory diseases were the third leading cause of death in 2017 (7.0% [95% UI 6.8-7 .2] of all deaths), behind cardiovascular diseases and neoplasms. Deaths due to chronic respiratory diseases numbered 3 914 196 (95% UI 3 790 578-4 044 819) in 2017, an increase of 18.0% since 1990, while total DALYs increased by 13.3%. However, when accounting for ageing and population growth, declines were observed in age-standardised prevalence (14.3% decrease), agestandardised death rates (42.6%), and age-standardised DALY rates (38.2%). In males and females, most chronic respiratory disease-attributable deaths and DALYs were due to COPD. In regional analyses, mortality rates from chronic respiratory diseases were greatest in south Asia and lowest in sub-Saharan Africa, also across both sexes. Notably, although absolute prevalence was lower in south Asia than in most other super-regions, YLLs due to chronic respiratory diseases across the subcontinent were the highest in the world. Death rates due to interstitial lung disease and pulmonary sarcoidosis were greater than those due to pneumoconiosis in all super-regions. Smoking was the leading risk factor for chronic respiratory disease-related disability across all regions for men. Among women, household air pollution from solid fuels was the predominant risk factor for chronic respiratory diseases in south Asia and sub-Saharan Africa, while ambient particulate matter represented the leading risk factor in southeast Asia, east Asia, and Oceania, and in the Middle East and north Africa super-region.
Interpretation Our study shows that chronic respiratory diseases remain a leading cause of death and disability worldwide, with growth in absolute numbers but sharp declines in several age-standardised estimators since 1990. Premature mortality from chronic respiratory diseases seems to be highest in regions with less-resourced health systems on a per-capita basis